|
Correlation
between NY-ESO-1 mRNA expression in primary lesions and
NY-ESO-1 antibody response in prostate cancer patients.
|
mRNA
|
Ab
|
No.
of Cases
|
|
+
|
+
|
2
|
|
+
|
-
|
18
|
|
-
|
+
|
1a
|
|
-
|
-
|
32
|
|
Total
|
53
|
aNY-ESO-1
mRNA expression was negative in the primary tumor, but was not
determined in metastatic lymph nodes (see text).
|
